Stefan Glocker

Learn More
PURPOSE To evaluate the Vienna Rectoscopy Score (VRS) as a feasible and effective tool for detecting and classifying pathologic changes in the rectal mucosa after radiotherapy (RT) for prostate cancer, and, also, to correlate its findings with the European Organization for Research and Treatment of Cancer (EORTC)/Radiation Therapy Oncology Group (RTOG)(More)
PURPOSE This retrospective analysis investigated the effectiveness and side-effects of combined hyperthermia and radiation therapy in locally recurrent breast cancer after primary modified radical mastectomy. The aim of the thermoradiotherapy was to reduce the substantial risk of symptomatic chest wall disease. MATERIALS AND METHODS Between May(More)
Evaluation of late side effects and biochemical control (bNED) 5 years after three-dimensional radiotherapy with moderate, risk-adapted dose escalation. From 03/1999 to 07/2002, 486 patients have been registered in the prospective Austrian-German multicenter phase II trial (AUGE). 399 (82%) localized prostate cancer patients (T1–3 Nx/N0 M0) were evaluated.(More)
Different radiotherapy techniques are used for postmastectomy irradiation. We review the results with the electron-beam-rotation technique in advanced breast cancer patients. Main endpoint was local tumor control. Patients and Methods: From 1990 to 1998 119 patients with adverse pathology features (pT3 17% of patients, pT4 42%, multicentricity 36%, pN ≥ 3(More)
HINTERGRUND: In der 3 dimensionalen Radiotherapie des lokalisierten Prostatakarzinoms wird zur Fixierung der Prostata und zur Verminderung der Strahlendosis an der Rektumhinterwand ein Rektumballon verwendet. Ziel dieser Studie war die Evaluierung der klinischen Anwendbarkeit eines Rektumballonkatheters, dessen Patientenakzeptanz und Untersuchung des(More)
Der Kalkulations- und Anpassungsprozess für 2005 wurde mit der fristgerecht vom deutschen DRG-Institut (InEK) vorgelegten Version 2005 des G-DRG-Systems, auf welches sich die Deutsche Krankenhausgesellschaft und die Spitzenverbände der gesetzlichen und privaten Krankenkassen (Selbstverwaltungspartner) am 16.09.2004 geeinigt haben, abgeschlossen. Bei der(More)
PURPOSE In Germany a new casemix-related reimbursement system with "diagnosis related groups" (DRGs) for inpatient treatment was started in 2003. The first German system G-DRG 1.0 was developed on the basis of the Australian AR-DRG version 4.1. German inpatient treatment in radiation oncology was not specifically represented in this system due to the very(More)
The RTOG 94-13 trial has provided evidence that patients with high risk prostate cancer benefit from an additional radiotherapy to the pelvic nodes combined with concomitant hormonal ablation. Since lymphatic drainage of the prostate is highly variable, the optimal target volume definition for the pelvic lymph nodes is problematic. To overcome this(More)
PURPOSE A German multicenter randomized trial (ARO 95-6) compared hyperfractionated accelerated radiotherapy (RT) alone (to a total radiation dose of 77.6 Gy) with hyperfractionated accelerated radiochemotherapy (to 70.6 Gy) using concurrent mitomycin C and 5-fluorouracil. We analyzed the baseline patient characteristics and the influence of physician(More)